New Jersey State Board of Medical Examiners advertising rules — a working guide
A field guide for practice operators, marketing directors and agency leads working with New Jersey physicians. New Jersey is one of the more prescriptive advertising rule sets in US medicine — NJAC 13:35-6.10 spells out explicit line-by-line requirements for testimonials, guarantees, comparative claims, board-certification language and advertisement record retention. Read alongside HIPAA, TCPA, FTC and the New Jersey Consumer Fraud Act.
- New Jersey physician advertising sits under NJAC 13:35-6.10, administered by the State Board of Medical Examiners. It is one of the more prescriptive state rule sets — with explicit provisions on false or misleading claims, testimonials, guarantees, comparative claims, before-and-after photography, and record retention.
- Advertisements must be kept on file for three years, including the date and the media in which each ran. This is a real operational obligation, not a paper formality — a Board investigator can request the file.
- Guarantees of specific outcomes and "board certified" claims from non-recognized certifying bodies are the two most frequently cited categories in NJ advertising discipline. The working rule is: never guarantee, and never call yourself "board certified" without an ABMS, BOS or Board-recognized equivalent.
- The New Jersey Consumer Fraud Act (NJSA 56:8) layers a separate civil track on top of the Board rule. A misleading healthcare ad in NJ can trigger a Board complaint and a Consumer Fraud Act claim with treble damages available.
- This is marketing guidance, not legal advice. Consult a New Jersey healthcare-marketing attorney and the Board before publishing anything close to the line.
- Dallas, Texas LLC
- 10-person US client team · Central Time (CST)
- 25+ US healthcare clients
- BAA signed with every client
- HIPAA compliance training across client and delivery teams
- Contracts and invoices in USD
-
Primary Care · North Dallas, TXCase study →
-
MedSpa · North Dallas, TX
-
Skin Care · Beverly Hills, CA
-
Dental · Christiansburg, VACase study →
-
Pediatrics · Blacksburg, VACase study →
-
Pediatric Dentistry · Blacksburg, VACase study →
-
Dental · Roanoke, VACase study →
-
Functional Medicine · Telehealth · USACase study →
“They were able to get all my ideas and work with me over a period of three to four months and create this amazing website. It's super customized, very modern, and it incorporates all the elements that I had wanted — the patient portal, nice pictures, a very interactive website, patient reviews. I would highly recommend their company to anyone who wants to make an excellent website.”
On this page
The authority: NJSA 45:9 and NJAC 13:35-6.10
The New Jersey State Board of Medical Examiners licenses and disciplines physicians, physician assistants, podiatrists, midwives, acupuncturists and several other health professions under Chapter 9 of Title 45 of the New Jersey Statutes Annotated. The Board is administratively housed inside the New Jersey Division of Consumer Affairs, which sits within the Office of the Attorney General — an unusual placement that shapes enforcement culture. Consumer complaints reach the Board through a channel that is, by design, oriented toward consumer protection.
The Board's rules of professional conduct sit at Title 13, Chapter 35 of the New Jersey Administrative Code. The advertising rule is NJAC 13:35-6.10. Unlike states that rely on a general "unprofessional conduct" head to reach advertising, New Jersey wrote a purpose-built advertising rule with line-by-line categories. The consequence is that a marketing team can — and should — read the rule directly rather than infer it from disciplinary orders.
The prohibited categories — a line-by-line read
NJAC 13:35-6.10 identifies specific advertising practices as prohibited. Reading them as a checklist is the fastest way to calibrate a New Jersey ad-review workflow.
- An advertisement that contains a false, fraudulent, deceptive or misleading statement.
- An advertisement that contains a misrepresentation of fact.
- An advertisement that is likely to create an unjustified expectation of the results a licensee can achieve.
- A guarantee of a specific outcome or a claim that a specific result is "guaranteed".
- A comparative claim that is not factually supportable and cannot be substantiated on request.
- A claim of unique or exclusive capability that is not factually supportable.
- A testimonial that fails to meet the rule's authenticity, typicality and disclosure requirements.
- A claim of "board certified" from a certifying body the Board does not recognize as substantially equivalent to ABMS or BOS.
The three-year record retention rule
New Jersey is one of the few states that imposes an explicit advertisement record-retention obligation on physicians. Under NJAC 13:35-6.10, a copy of every advertisement — including the date of publication and the media in which it appeared — must be retained for at least three years and made available to the Board on request. The retention obligation is a real operational duty, not a formality, and its absence is what an investigator will flag if a complaint reaches the Board.
Operationally, the working control is a single "ad register" — a spreadsheet or lightweight database — that captures for every published ad: the creative (or a stable link to it), the date first published, the date last published, the platforms and placements, the internal approvers, the version of the disclaimer used, and the HIPAA-authorization reference where testimonials or patient images are involved. Every quarter, the register is exported and archived. Every ad campaign is booked into the register before it goes live.
Testimonials, endorsements and reviews
New Jersey permits patient testimonials in advertising, but the rule places explicit conditions on their use. The testimonial must be authentic. It must reflect the endorser's genuine experience. It must not create an unjustified expectation about the results a patient can reasonably achieve. Any material connection between the endorser and the practice must be disclosed in the advertisement itself.
Two federal duties layer on. The FTC Endorsement Guides at 16 CFR Part 255 require disclosure of any material connection — payment, free treatment, discount, employment. HIPAA's marketing-authorization rule at 45 CFR 164.508 requires a specific authorization from the patient for the specific use of their identity, condition or care in marketing. A testimonial that is fine under NJAC 13:35-6.10 can still be a HIPAA violation or an FTC-actionable failure to disclose. All three layers should be checked before publish.
Reviews as advertising
Third-party review responses are treated as an act of the practice, not the reviewer. A response confirming a specific patient's care is a HIPAA disclosure. A response that solicits new business on a public surface starts to look like targeted marketing. The safe pattern is neutral, de-identified acknowledgment and a request to continue offline via patient services.
"Board certified" and specialty claims
"Board certified" in New Jersey has a narrow, defensible meaning. A physician may hold themselves out as board certified when the certifying body is a member board of the American Board of Medical Specialties, a Bureau of Osteopathic Specialists board, the Royal College of Physicians and Surgeons of Canada, or an equivalent that the NJ Board treats as substantially equivalent for the discipline in question. The claim must reflect a current certification — a lapsed certification cannot support "board certified" language.
The corollary is a working list of certifying bodies that will not, on their own, support a "board certified" claim in NJ marketing. Many private, single-specialty or niche certifying bodies fall into this category. The Board treats a "board certified" claim resting on a non-recognized body as misleading. The practical control is a written, referenced list of the certifying bodies the practice accepts as supporting a "board certified" claim, cross-referenced against each physician's current certificates.
Before-and-after and results imagery
Before-and-after photography is permitted when the imagery is truthful, unretouched, of actual patients of the practice, taken under comparable lighting, distance and angle, representative of the range of typical results, and accompanied by conspicuous disclosure that individual results vary. A HIPAA marketing authorization for the specific use of the imagery must be on file — signed by the patient before the imagery is published.
New Jersey applies a strict "conspicuous" test. A results-vary disclaimer buried in a footer, or hidden in a color so close to the background that a reasonable reader would not perceive it, does not meet the rule. The working control is that any disclaimer supporting a results claim shares the visual weight, font size and color contrast of the claim itself, and appears in the same eye-tracking zone.
Stock imagery
Stock imagery is defensible for contextual shots — waiting rooms, exteriors, staff — provided the imagery is not presented in a way that suggests it depicts the practice's own outcomes or the practice's own patients. Where stock imagery accompanies a services page for a specific procedure, a small "illustrative only" note in a legible size and color is the working control.
The Consumer Fraud Act overlay — NJSA 56:8
The New Jersey Consumer Fraud Act (NJSA 56:8-1 et seq.) is one of the most consumer-friendly state fraud statutes in the country. It prohibits any unconscionable commercial practice, deception, fraud, false pretense, false promise, or misrepresentation in connection with the sale or advertisement of any merchandise or service. For healthcare advertising, the CFA is the parallel civil track that runs alongside the Board rule.
Two features of the CFA change the calculus for NJ healthcare advertising. First, the statute provides for treble damages plus attorney's fees when a consumer establishes an unlawful practice and an ascertainable loss. Second, the Attorney General's Division of Consumer Affairs — which houses the Board of Medical Examiners — can bring parallel enforcement actions. A misleading fee, a false comparative claim, or an unsubstantiated results promise can trigger a Board complaint, an AG enforcement action, and a private class action simultaneously.
A working New Jersey review playbook
The most reliable way to translate NJAC 13:35-6.10 into daily marketing operations is a short, written playbook. New Jersey is an unusually prescriptive rule set — the payoff of a documented playbook is high because the rule's line-by-line categories give a reviewer a clear checklist to work against.
- Pre-brief. Every campaign brief carries a claim list — every specific claim the campaign will make, in plain language, before creative is written.
- Prohibited-list check. Copy is read against the NJAC 13:35-6.10 prohibited categories — false/misleading claims, misrepresentations, unjustified-expectation claims, outcome guarantees, unsupportable comparative claims, unique-capability claims, testimonial rules, and "board certified" support.
- Substantiation folder. Every retained claim has a substantiation reference filed in a shared folder — study, internal record, certification document, or a dated screenshot. If a claim has no reference, the claim is cut.
- HIPAA gate. No PHI-tracking pixels on condition or symptom pages. HIPAA authorizations on file for testimonial patients and imagery, dated before publication.
- FTC endorsement check. Every endorsement in the campaign has a material-connection line inside the ad itself, not a separate disclosures page.
- NJ ad register. Every published asset is booked in with live-dates, media, disclaimers, HIPAA-authorization references and approver names. Retained for a minimum of three years.
The register is the single artefact that separates a New Jersey practice with a defensible marketing program from one that is exposed. On investigation, the register (or its absence) frames what the Board sees first. A practice that can produce a clean register for the last three years usually settles a complaint at the letter-of-concern level. A practice that cannot produce a register at all usually escalates.
New Jersey medical advertising — common questions
What are the New Jersey advertising rules for physicians?
NJAC 13:35-6.10 sets out the advertising rules — false/misleading claims, testimonials, guarantees, comparative claims, before-and-after photos and record retention are all addressed explicitly.
Does NJ require records of past advertisements to be kept?
Yes. Every advertisement — with date and media — must be retained for at least three years and produced to the Board on request.
Are before-and-after photos allowed?
Yes when the imagery is unretouched, of actual patients, representative, obtained with HIPAA authorization, and paired with a conspicuous results-vary disclosure.
Can a NJ physician say "board certified" in an ad?
Only when certified by ABMS, BOS, RCPSC or a certifying body the NJ Board recognizes as substantially equivalent, and only where the certification is currently active.
Are guarantees of results banned?
Yes. Statements guaranteeing a specific outcome or creating an unjustified expectation of a specific result are explicitly prohibited.
What penalties can the Board impose?
Reprimands, monetary penalties, probation, license suspension, revocation, remedial coursework. The Consumer Fraud Act adds a separate civil track with treble damages.
Is this legal advice?
No. This is marketing best practice reviewed for alignment with NJ Board rules. Every regulated advertisement should be cleared by a healthcare-marketing attorney and the practice's Compliance Officer before publish.
Scope a New Jersey advertising review
Book a 30-minute call with a member of the Leadership Team, email the US practice lead, or WhatsApp us in your time zone. Retainers custom-scoped per engagement · from 9/month.